menu
    • menu
    [{"orgOrder":0,"company":"Engine Biosciences","sponsor":"Polaris Partners","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"SINGAPORE","productType":"Other Small Molecule","year":"2023","type":"Series A Financing","leadProduct":"ENB-812","moa":"Undisclosed","graph1":"Oncology","graph2":"IND Enabling","graph3":"Engine Biosciences","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Engine Biosciences \/ Polaris Partners","highestDevelopmentStatusID":"5","companyTruncated":"Engine Biosciences \/ Polaris Partners"}]

    Find Clinical Drug Pipeline Developments & Deals by Engine Biosciences

    Menu

    Engine Biosciences

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Engine Biosciences

                            Singapore arrow
                            Legal Affairs
                            Not Confirmed

                            Engine Biosciences

                            Singapore arrow
                            Legal Affairs
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ENB-812

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Polaris Partners

                            Deal Size : $86.0 million

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            Engine Biosciences Secures $27 Million Series A Extension to Advance Development of Precision Oncology Medicin...

                            Details : The financing will advance development of precision oncology medicines, including ENB-812, a drug that inhibits PKMYT1, and novel biomarkers for patient selection.

                            Product Name : ENB-812

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            October 31, 2023

                            Lead Product(s) : ENB-812

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Polaris Partners

                            Deal Size : $86.0 million

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth